MedicinMan | Amplifying Healthcare Voices

Thursday, February 26, 2026

30 C

Bengaluru

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of...

Biologics Anup Soans - February 25, 2026

The Paradox of Protection In the time it takes to read this sentence, roughly 500...

Exclusive Articles

Strategic Communications for Healthcare Brands

Special Issue

Fostering Thought leadership in Healthcare

Biologics

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

The Paradox of Protection In the time it takes to...

Featured Article

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Exclusive Articles

Quality, Not Price: Why the Generic Drug Debate Keeps Missing the Point

In an earlier article in The Wire Science, I...

IMS Monthly Market Reflection Report

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Healthcare News

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Exclusive Articles

Worldclass Healthcare But Out of Reach for Most Indians?

When an eminent cardiologist like Dr. Sunil Chandy—former Director...

Exclusive Articles

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to...

Healthcare News

Cipla–Pfizer Deal: How “Ordinary” Brands Are Fueling an Extraordinary Power Shift in Indian Pharma

What’s really happening in the Cipla–Pfizer tie‑up At first glance,...

Topics

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

Exclusive Articles February 13, 2026

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

Exclusive Articles February 12, 2026

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

Exclusive Articles February 11, 2026

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

The Uncomfortable Truth about Indian Generics: Untangling the Conundrum

Exclusive Articles February 3, 2026

Quality, Not Price: Why the Generic Drug Debate Keeps Missing the Point

Exclusive Articles February 1, 2026

IQVIA vs. PharmaTrac: Indian Pharma Market Data

IMS Monthly Market Reflection Report January 29, 2026

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

March 3, 2025 0

1. Market Overview The oncology sector remains the most dominant...

AI in Healthcare

Blinkit, Zepto, Instamart: Who Will Own India’s At‑Home Diagnostics Market?

November 30, 2025 0

India’s diagnostics market is undergoing a quiet but profound...

Popular Categories

Featured Article83 Healthcare News47 Leaderspeak46 Special Issue45 Exclusive Articles43 Thought Leadership19

Video Insights

MedicinMan CEO Insights - Leading with Empathy: Mankind's Success Story.

02:30

MedicinMan CEO Insights - The Rise of Digital Apps in Healthcare

00:49

MedicinMan CEO Insights - Transforming Healthcare: Technology in Fertility and Pharma #medicinman

02:52

MedicinMan CEO Insights - How Tech is Revolutionizing Doctor-Patient Engagement. #medicinman

02:43

Head Start - Six Key Skills for Your Career's Success #keytakeaways #medicinman #anupsoans

02:25

Head Start - Six Key Skills for Your Career's Success #AdviceToYoungerSelf #medicinman #anupsoans

01:45

Headlines

The Uncomfortable Truth about Indian Generics: Untangling the Conundrum

Exclusive Articles Anup Soans - February 3, 2026

India’s pharmaceutical industry occupies a unique and powerful position in global healthcare. It supplies nearly half of all generic...

Worldclass Healthcare But Out of Reach for Most Indians?

Exclusive Articles Anup Soans - December 29, 2025

When an eminent cardiologist like Dr. Sunil Chandy—former Director at CMC Vellore—calls out the "medical colonialism and exploitation that...

Exclusive Articles

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

February 24, 2026

On February 13, 2026, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recommended the withdrawal of...

Digital Noise to Digital Voice – A 4-Module Workshop for Pharma People

Special Announcement Anup Soans - October 14, 2021

National Seminar on UCPMP

Special Announcement Anup Soans - August 20, 2016

Music

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

Aflibercept: When Originators Stop Fighting and Start Licensing

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

Food

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

Aflibercept: When Originators Stop Fighting and Start Licensing

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...

Samuel Paradise

Biologics

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

Exclusive Articles

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

Exclusive Articles

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

Biologics

Aflibercept: When Originators Stop Fighting and Start Licensing

Featured Article

India’s Pharma Renaissance: Private Equity at the Helm

Manuela Cole

Biologics

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

Exclusive Articles

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

Exclusive Articles

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

Biologics

Aflibercept: When Originators Stop Fighting and Start Licensing

Featured Article

India’s Pharma Renaissance: Private Equity at the Helm

Keisha Adams

Biologics

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

Exclusive Articles

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

Exclusive Articles

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

Biologics

Aflibercept: When Originators Stop Fighting and Start Licensing

Featured Article

India’s Pharma Renaissance: Private Equity at the Helm

George Pharell

Biologics

The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health

Exclusive Articles

Levamisole Withdrawn in EU: Will India’s Regulator Follow?

Exclusive Articles

Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now

Biologics

Aflibercept: When Originators Stop Fighting and Start Licensing

Featured Article

India’s Pharma Renaissance: Private Equity at the Helm

Leaders Speak

Business leaders sharing their insights

Salil Kallianpur

14 POSTS

http://salilkallianpur.wordpress.com

8 POSTS

6 POSTS

6 POSTS

5 POSTS

5 POSTS

3 POSTS

https://www.enparadigm.com/

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

.st0{fill:#FFFFFF;} .st1{fill:#E52E2E;}

Hot topics

Healthcare Trends

Marketing

Policies/Sales

Strategy

Hot topics

Healthcare Trends

Marketing

Policies/Sales

Strategy

Topics

Follow Us

Video Insights

Headlines

Music

Food

Leaders Speak

Business leaders sharing their insights

Company

Headlines

Newsletter